School of Life Sciences, Anhui University, Hefei 230601, Anhui, China; Key Laboratory of Ecological Engineering and Biotechnology of Anhui Province and Anhui Key Laboratory of Modern Biomanufacturing, Hefei, Anhui, China.
School of Life Sciences, Anhui University, Hefei 230601, Anhui, China; Key Laboratory of Ecological Engineering and Biotechnology of Anhui Province and Anhui Key Laboratory of Modern Biomanufacturing, Hefei, Anhui, China.
Int J Biol Macromol. 2022 Jul 31;213:967-986. doi: 10.1016/j.ijbiomac.2022.06.049. Epub 2022 Jun 11.
Intestinal dysbiosis is one of the major causes of the occurrence of metabolic syndromes, such as obesity, diabetes, nonalcoholic fatty liver disease, and cardiovascular diseases. Polysaccharide-based microbial therapeutic strategies have excellent potential in the treatment of metabolic syndromes, but the underlying regulatory mechanisms remain elusive. Identification of the internal regulatory mechanism of the gut microbiome and the interaction mechanisms involving bacteria and the host are essential to achieve precise control of the gut microbiome and obtain valuable clinical data. Polysaccharides cannot be directly digested; the behavior in the intestinal tract is considered a "bridge" between microbiota and host communication. To provide a relatively comprehensive reference for researchers in the field, we will discuss the polysaccharide extraction and purification processes and chemical and structural characteristics, focusing on the polysaccharides in gut microbiota through the immune system, gut-liver axis, gut-brain axis, energy axis interactions, and potential applications.
肠道菌群失调是肥胖、糖尿病、非酒精性脂肪肝和心血管疾病等代谢综合征发生的主要原因之一。基于多糖的微生物治疗策略在治疗代谢综合征方面具有巨大的潜力,但潜在的调控机制仍不清楚。鉴定肠道微生物组的内部调控机制以及涉及细菌和宿主的相互作用机制对于实现对肠道微生物组的精确控制和获得有价值的临床数据至关重要。多糖不能被直接消化;其在肠道中的行为被认为是微生物群和宿主之间通讯的“桥梁”。为了给该领域的研究人员提供一个相对全面的参考,我们将讨论多糖的提取和纯化过程以及化学和结构特征,重点是通过免疫系统、肠-肝轴、肠-脑轴、能量轴相互作用的肠道微生物组中的多糖及其潜在应用。